All Q3 FY25 results →
BC

Bodal Chemicals Ltd

Q3 FY25Chemicals & Petrochemicals

Bodal Chemicals Q3 FY25 earnings call: Revenue & Margins

Q3 FY25 earnings call: what management guided on revenue, margins and order book.

Price₹79
Market cap₹950 Cr
P/E13.8
Updated23 Aug 2026
Read4 min read

The short version

Chemical industry has recovered with improved volumes and demand over recent months. Bodal Chemicals targets Rs.

From Bodal Chemicals Ltd's Q3 FY25 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Chemical industry has recovered with improved volumes and demand over recent months.
  • Bodal Chemicals targets achieving an annual turnover of Rs. 2,000+ crores within the next 3-4 months.
  • Benzene downstream project is expected to add around Rs. 300 crore annually at optimum (80%-90%) utilization in next couple of quarters.
  • Current EBITDA levels are around 13% to 14%, expected to sustain or improve to 12%-15% in coming quarters.
  • Dye intermediate capacity utilization near 90%, dyestuff at 56% with scope for growth.
  • No major CAPEX planned in next 4-6 quarters; focus is on consolidating recent expansions.
  • Salt-free dyes project to add incremental revenues post stabilization in 4-6 months.

2 more points from Bodal Chemicals Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Bodal Chemicals Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Bodal Chemicals has recently invested heavily in the Saykha Greenfield benzene derivatives project with a total project cost (excluding one-time infrastructural cost) of about Rs. 400-450 crore. Around 70% of this was funded through debt and 30% through internal accruals.
  • No immediate plans for major CAPEX in the next 4 to 6 quarters; current focus is on consolidating recent capital expenditures.
  • Evaluating renewable energy initiatives (solar power) for power cost optimization, but potential savings are small (~Rs. 20-30 crore annual power spend with 5% savings estimated at a couple of crores), so capital is preferred to be employed in business growth rather than renewables at present.

2 more points from Bodal Chemicals Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Bodal Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript does not explicitly mention the current or expected order book or pending orders for Bodal Chemicals Limited. However, relevant related points include: - The Company has achieved a topline run rate of Rs. 1700 crore recently, targeting to exceed Rs. 2000 crore annually within a few months with increasing volumes. - The benzene downstream project, currently underutilized (~13-14%), is expected to scale up production and contribute around Rs. 300 crore of annual turnover once at 80-90% utilization, likely within the next few quarters.

2 more points from Bodal Chemicals Ltd's call on order book

Pro opens every point from 15K+ earnings calls

Bodal Chemicals Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹588 Cr, net profit ₹32 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Himadri Special (Q3 FY25)

    1,131.81 Crs, up 7.53% YoY (from Rs. Key concall takeaways from Himadri Speciality Chemical Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.

  • Gujarat Alkalies (Q3 FY25)

    3,702.77 Crores (up from Rs. Key concall takeaways from Gujarat Alkalies & Chemicals Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.

  • Balaji Amines (Q3 FY25)

    Q3FY25 consolidated revenue from operations was ₹321 crore, down 18% YoY from ₹392 crore in Q3FY24 (Page 7). Key concall takeaways from Balaji Amines Ltd's Q3…

  • Vidhi Specialty (Q3 FY25)

    Year-on-Year (Y-o-Y) Growth:** 56.5% increase . Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q3 FY25 earnings call — and how it ranks…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Bodal Chemicals Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Bodal Chemicals Ltd Q3 FY25 results?

Chemical industry has recovered with improved volumes and demand over recent months. Bodal Chemicals targets Rs.

What is Bodal Chemicals Ltd share price analysis?

Bodal Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 13.8 with a market cap of ₹950 Cr. Investors should review the full earnings analysis for detailed insights.

Is Bodal Chemicals Ltd planning capital expenditure?

Bodal Chemicals has recently invested heavily in the Saykha Greenfield benzene derivatives project with a total project cost (excluding one-time infrastructural cost) of about Rs.

Keep Bodal Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.